Clinical trial
Longitudinal Metabolite Levels in Patients Receiving Maintenance PARP Inhibitors
NCT04917744 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Longitudinal Metabolite Levels in Patients Receiving Maintenance PARP Inhibitors
- Lead sponsor
- Mayo Clinic
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 1, 2021
- Completion date
- February 17, 2024
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ovarian carcinoma